Healthcare Industry News:  StrataDx 

Diagnostics Personnel

 News Release - November 8, 2011

Pat Noland Appointed StrataDx Chief Executive Officer

LEXINGTON, Mass., Nov. 8, 2011 -- (Healthcare Sales & Marketing Network) -- StrataDx, a leader in anatomic pathology, has named former LabCorp executive, Pat Noland, CEO. Since 1984, StrataDx has partnered with clinicians to provide the best care to patients through its high-quality pathology services in the dermatology, urology, podiatry, oral pathology, gastroenterology, and gynecology segments.

Mr. Noland's appointment is a key milestone for StrataDx following the recent equity investment by Linden Capital Partners. According to Brian Miller, a member of the StrataDx board and Linden managing partner, "Pat is the ideal leader to take StrataDx to the next level as it broadens its testing menu to include the latest in molecular pathology and expands its outreach to bring Strata's best-in-class client service and clinical expertise to a significantly wider customer base."

Mr. Noland joins StrataDx after 17 years at the $5 billion clinical-laboratory company, Laboratory Corporation of America. Mr. Noland was most recently senior vice president responsible for developing and implementing LabCorp's hospital strategy. Previously, Mr. Noland held full P&L responsibility for DIANON Systems, LabCorp's anatomic pathology business, as well as a series of other senior leadership roles.

"I'm thrilled to join StrataDx, which is exceptionally positioned for growth," commented Noland. "World-renowned dermatopathologist and educator, Geoffrey Gottlieb, M.D., has joined Terence Harrist, M.D. as co-director of Strata's dermatopathology department, placing two of the leading dermatopathologists in the same practice. Additionally, we have experienced impressive growth in other specialties due to our quality, expertise, and focus on the customer and patient. We look forward to expanding those services beyond our core geographic market."

About StrataDx (www.StrataDx.com)

StrataDx is a full-service anatomic pathology laboratory. The company offers services in all areas of surgical pathology and cytology, as well as molecular diagnostics and immunofluorescence. The pathology team has members with subspecialty board certifications in dermatopathology, hematopathology, cytopathology, nuclear medicine, and clinical pathology and the majority of the pathologists have more than 20 years of medical experience. StrataDx serves customers ranging from major regional hospitals to small independent physician practices in more than 40 states. Headquartered in Lexington, Massachusetts, with additional facilities in Cambridge, the company has more than 100 employees.

About Linden Capital Partners (www.lindenllc.com)

Linden is a Chicago-based private equity firm focused exclusively on leveraged buyouts in the healthcare and life science industries. Linden's investment strategy is based upon three elements: i) healthcare and life science industry specialization, ii) integrated private equity and operating expertise, and iii) strategic relationships with large corporations. Linden currently manages $575 million in capital.


Source: StrataDx

Issuer of this News Release is solely responsible for its content.
Please address inquiries directly to the issuing company.



FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.